Current gaps in knowledge in inherited arrhythmia syndromes

Area of Science:

• Cardiology
• Genetics
• Clinical Medicine

Background:

• The three most common inherited arrhythmia syndromes, Brugada syndrome, congenital long QT syndrome, and catecholaminergic polymorphic ventricular tachycardia, were identified last century.
• Advances in research have improved early identification of at-risk patients, yet significant knowledge gaps persist.
• These gaps complicate the clinical management of individuals diagnosed with these inherited cardiac conditions.

Purpose of the Study:

• To identify and discuss the most significant knowledge gaps in the clinical research of Brugada syndrome, congenital long QT syndrome, and catecholaminergic polymorphic ventricular tachycardia.
• To provide a comprehensive overview of current challenges in managing patients with these inherited arrhythmia syndromes.
• To guide future research directions by pinpointing areas requiring further investigation.

Main Methods:

• This review synthesizes current scientific literature on inherited arrhythmia syndromes.
• Key knowledge gaps in diagnosis, risk stratification, and therapeutic strategies were identified.
• The focus is on Brugada syndrome, congenital long QT syndrome, and catecholaminergic polymorphic ventricular tachycardia.

Main Results:

• Significant gaps exist in understanding the genotype-phenotype correlations for these syndromes.
• Current diagnostic criteria and risk stratification tools require refinement.
• Optimal long-term management strategies and the role of novel therapies remain incompletely defined.

Conclusions:

• Despite advances, substantial knowledge gaps hinder optimal clinical management of Brugada syndrome, congenital long QT syndrome, and catecholaminergic polymorphic ventricular tachycardia.
• Further research is essential to refine diagnostic approaches, improve risk prediction, and establish evidence-based treatment guidelines.
• Addressing these gaps will improve the quality of life and reduce the risk of sudden cardiac death in affected individuals.